nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—Paclitaxel—kidney cancer	0.216	1	CbGbCtD
Cyproterone acetate—NR3C1—urine—kidney cancer	0.00326	0.23	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—TSC2—kidney cancer	0.00114	0.00968	CbGpPWpGaD
Cyproterone acetate—CYP19A1—gonad—kidney cancer	0.00112	0.0787	CbGeAlD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.00111	0.00945	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.0011	0.00939	CbGpPWpGaD
Cyproterone acetate—AR—renal system—kidney cancer	0.0011	0.0777	CbGeAlD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—kidney cancer	0.00109	0.00925	CbGpPWpGaD
Cyproterone acetate—AR—kidney—kidney cancer	0.00106	0.0751	CbGeAlD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.00106	0.00902	CbGpPWpGaD
Cyproterone acetate—AR—cortex of kidney—kidney cancer	0.00104	0.0731	CbGeAlD
Cyproterone acetate—AR—gonad—kidney cancer	0.000988	0.0697	CbGeAlD
Cyproterone acetate—AR—cardiac atrium—kidney cancer	0.000987	0.0696	CbGeAlD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.000978	0.00833	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000907	0.00772	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000907	0.00772	CbGpPWpGaD
Cyproterone acetate—NR3C1—nephron tubule—kidney cancer	0.000878	0.0619	CbGeAlD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000852	0.00725	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HIF1A—kidney cancer	0.000851	0.00724	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000843	0.00717	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.000842	0.00716	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A1—kidney cancer	0.000838	0.00713	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—ALDH1A1—kidney cancer	0.000822	0.007	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—RAF1—kidney cancer	0.000821	0.00698	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.000815	0.00693	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—KDR—kidney cancer	0.000814	0.00692	CbGpPWpGaD
Cyproterone acetate—NR3C1—renal system—kidney cancer	0.000798	0.0563	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—RAF1—kidney cancer	0.000789	0.00671	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	0.000784	0.00667	CbGpPWpGaD
Cyproterone acetate—NR3C1—kidney—kidney cancer	0.000771	0.0544	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MTOR—kidney cancer	0.00077	0.00655	CbGpPWpGaD
Cyproterone acetate—NR3C1—cortex of kidney—kidney cancer	0.000751	0.053	CbGeAlD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000736	0.00626	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.000721	0.00614	CbGpPWpGaD
Cyproterone acetate—NR3C1—gonad—kidney cancer	0.000715	0.0505	CbGeAlD
Cyproterone acetate—NR3C1—cardiac atrium—kidney cancer	0.000714	0.0504	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000689	0.00586	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000677	0.00576	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.000675	0.00574	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000668	0.00569	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000664	0.00565	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.000632	0.00538	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—kidney cancer	0.000631	0.00537	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000626	0.00533	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000626	0.00533	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000618	0.00526	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000594	0.00506	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000593	0.00505	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.000592	0.00503	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—kidney cancer	0.000573	0.00488	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000573	0.00487	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000573	0.00487	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.000569	0.00484	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK3—kidney cancer	0.000569	0.00484	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—CDKN1B—kidney cancer	0.000568	0.00484	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.000563	0.00479	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000558	0.00475	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000557	0.00474	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000549	0.00467	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK1—kidney cancer	0.000541	0.0046	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.000541	0.0046	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.000539	0.00459	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000522	0.00445	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000516	0.00439	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000514	0.00437	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000505	0.0043	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.000494	0.0042	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000493	0.00419	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000493	0.00419	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.00049	0.00417	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.000489	0.00416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTT1—kidney cancer	0.000483	0.00411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000479	0.00408	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000474	0.00404	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000469	0.00399	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000469	0.00399	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000468	0.00399	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000466	0.00397	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—PTGS1—kidney cancer	0.000453	0.00385	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.000451	0.00384	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000442	0.00376	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000426	0.00362	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000426	0.00362	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000423	0.0036	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000422	0.00359	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.000417	0.00355	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.000413	0.00352	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000409	0.00348	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000399	0.0034	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000398	0.00339	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000398	0.00338	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HARS—kidney cancer	0.000383	0.00326	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000363	0.00309	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000355	0.00302	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000354	0.00301	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000351	0.00299	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.00035	0.00298	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	0.000347	0.00295	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000347	0.00295	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Capecitabine—kidney cancer	0.000339	0.00052	CcSEcCtD
Cyproterone acetate—Hepatitis—Capecitabine—kidney cancer	0.000339	0.00052	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Gemcitabine—kidney cancer	0.000339	0.00052	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000339	0.00288	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000338	0.000519	CcSEcCtD
Cyproterone acetate—Hot flush—Doxorubicin—kidney cancer	0.000338	0.000518	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.000336	0.00286	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	0.000336	0.00286	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.000335	0.00285	CbGpPWpGaD
Cyproterone acetate—Menopausal symptoms—Doxorubicin—kidney cancer	0.000335	0.000514	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000335	0.000514	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTP1—kidney cancer	0.000335	0.00285	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Sorafenib—kidney cancer	0.000335	0.000513	CcSEcCtD
Cyproterone acetate—Anorexia—Gemcitabine—kidney cancer	0.000334	0.000513	CcSEcCtD
Cyproterone acetate—Vomiting—Vinblastine—kidney cancer	0.000334	0.000512	CcSEcCtD
Cyproterone acetate—Dizziness—Erlotinib—kidney cancer	0.000334	0.000512	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Paclitaxel—kidney cancer	0.000334	0.000512	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000334	0.00284	CbGpPWpGaD
Cyproterone acetate—Connective tissue disorder—Capecitabine—kidney cancer	0.000333	0.000511	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000333	0.00283	CbGpPWpGaD
Cyproterone acetate—Vomiting—Everolimus—kidney cancer	0.000333	0.00051	CcSEcCtD
Cyproterone acetate—Anaemia—Paclitaxel—kidney cancer	0.000333	0.00051	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000332	0.00283	CbGpPWpGaD
Cyproterone acetate—Agitation—Paclitaxel—kidney cancer	0.000331	0.000507	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTP1—kidney cancer	0.00033	0.00281	CbGpPWpGaD
Cyproterone acetate—Rash—Everolimus—kidney cancer	0.00033	0.000506	CcSEcCtD
Cyproterone acetate—Dermatitis—Everolimus—kidney cancer	0.00033	0.000506	CcSEcCtD
Cyproterone acetate—Headache—Vinblastine—kidney cancer	0.000329	0.000505	CcSEcCtD
Cyproterone acetate—Headache—Everolimus—kidney cancer	0.000328	0.000503	CcSEcCtD
Cyproterone acetate—Hypotension—Gemcitabine—kidney cancer	0.000328	0.000503	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dactinomycin—kidney cancer	0.000327	0.000502	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dactinomycin—kidney cancer	0.000327	0.000502	CcSEcCtD
Cyproterone acetate—Visual impairment—Capecitabine—kidney cancer	0.000327	0.000501	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EIF5B—kidney cancer	0.000326	0.00277	CbGpPWpGaD
Cyproterone acetate—Asthenia—Sorafenib—kidney cancer	0.000326	0.0005	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000326	0.00277	CbGpPWpGaD
Cyproterone acetate—Malaise—Paclitaxel—kidney cancer	0.000324	0.000498	CcSEcCtD
Cyproterone acetate—Cardiac failure—Doxorubicin—kidney cancer	0.000324	0.000497	CcSEcCtD
Cyproterone acetate—Syncope—Paclitaxel—kidney cancer	0.000323	0.000495	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000323	0.000495	CcSEcCtD
Cyproterone acetate—Leukopenia—Paclitaxel—kidney cancer	0.000322	0.000494	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Sunitinib—kidney cancer	0.000322	0.000494	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vincristine—kidney cancer	0.000321	0.000493	CcSEcCtD
Cyproterone acetate—Pruritus—Sorafenib—kidney cancer	0.000321	0.000493	CcSEcCtD
Cyproterone acetate—Vomiting—Erlotinib—kidney cancer	0.000321	0.000493	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Capecitabine—kidney cancer	0.000321	0.000492	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000319	0.00049	CcSEcCtD
Cyproterone acetate—Fatigue—Vincristine—kidney cancer	0.000319	0.000489	CcSEcCtD
Cyproterone acetate—Rash—Erlotinib—kidney cancer	0.000318	0.000488	CcSEcCtD
Cyproterone acetate—Dermatitis—Erlotinib—kidney cancer	0.000318	0.000488	CcSEcCtD
Cyproterone acetate—Eye disorder—Capecitabine—kidney cancer	0.000317	0.000486	CcSEcCtD
Cyproterone acetate—Headache—Erlotinib—kidney cancer	0.000316	0.000485	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Paclitaxel—kidney cancer	0.000316	0.000485	CcSEcCtD
Cyproterone acetate—Constipation—Vincristine—kidney cancer	0.000316	0.000485	CcSEcCtD
Cyproterone acetate—Cough—Paclitaxel—kidney cancer	0.000314	0.000482	CcSEcCtD
Cyproterone acetate—Asthenia—Sunitinib—kidney cancer	0.000314	0.000481	CcSEcCtD
Cyproterone acetate—Dyspnoea—Gemcitabine—kidney cancer	0.000313	0.00048	CcSEcCtD
Cyproterone acetate—Nausea—Vinblastine—kidney cancer	0.000312	0.000479	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—kidney cancer	0.000311	0.000477	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—kidney cancer	0.000311	0.000477	CcSEcCtD
Cyproterone acetate—Nausea—Everolimus—kidney cancer	0.000311	0.000477	CcSEcCtD
Cyproterone acetate—Diarrhoea—Sorafenib—kidney cancer	0.000311	0.000477	CcSEcCtD
Cyproterone acetate—Pruritus—Sunitinib—kidney cancer	0.000309	0.000474	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000309	0.00263	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000308	0.00262	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Capecitabine—kidney cancer	0.000308	0.000472	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—kidney cancer	0.000308	0.00262	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Capecitabine—kidney cancer	0.000306	0.00047	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Capecitabine—kidney cancer	0.000306	0.000469	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.000306	0.0026	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Gemcitabine—kidney cancer	0.000305	0.000468	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Dactinomycin—kidney cancer	0.000305	0.000468	CcSEcCtD
Cyproterone acetate—Chills—Capecitabine—kidney cancer	0.000304	0.000467	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000304	0.000467	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000303	0.00258	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000303	0.000465	CcSEcCtD
Cyproterone acetate—Discomfort—Paclitaxel—kidney cancer	0.000303	0.000464	CcSEcCtD
Cyproterone acetate—Fatigue—Gemcitabine—kidney cancer	0.000302	0.000464	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vincristine—kidney cancer	0.000302	0.000464	CcSEcCtD
Cyproterone acetate—Dizziness—Sorafenib—kidney cancer	0.0003	0.000461	CcSEcCtD
Cyproterone acetate—Constipation—Gemcitabine—kidney cancer	0.0003	0.00046	CcSEcCtD
Cyproterone acetate—Nausea—Erlotinib—kidney cancer	0.0003	0.00046	CcSEcCtD
Cyproterone acetate—Alopecia—Capecitabine—kidney cancer	0.0003	0.00046	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—kidney cancer	0.000299	0.000459	CcSEcCtD
Cyproterone acetate—Diarrhoea—Sunitinib—kidney cancer	0.000299	0.000459	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000298	0.00253	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	0.000297	0.00253	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Capecitabine—kidney cancer	0.000297	0.000456	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—kidney cancer	0.000297	0.000455	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000296	0.000454	CcSEcCtD
Cyproterone acetate—Malnutrition—Capecitabine—kidney cancer	0.000295	0.000453	CcSEcCtD
Cyproterone acetate—Oedema—Paclitaxel—kidney cancer	0.000294	0.000451	CcSEcCtD
Cyproterone acetate—Body temperature increased—Vincristine—kidney cancer	0.000292	0.000448	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vincristine—kidney cancer	0.000292	0.000448	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000292	0.000448	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—kidney cancer	0.000292	0.00248	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	0.000291	0.00248	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HARS—kidney cancer	0.000291	0.00248	CbGpPWpGaD
Cyproterone acetate—Dizziness—Sunitinib—kidney cancer	0.000289	0.000443	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Gemcitabine—kidney cancer	0.000289	0.000443	CcSEcCtD
Cyproterone acetate—Shock—Paclitaxel—kidney cancer	0.000289	0.000443	CcSEcCtD
Cyproterone acetate—Vomiting—Sorafenib—kidney cancer	0.000289	0.000443	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Paclitaxel—kidney cancer	0.000288	0.000442	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000288	0.00245	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000288	0.000441	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	0.000288	0.00245	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000287	0.00244	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Paclitaxel—kidney cancer	0.000287	0.00044	CcSEcCtD
Cyproterone acetate—Rash—Sorafenib—kidney cancer	0.000286	0.000439	CcSEcCtD
Cyproterone acetate—Dermatitis—Sorafenib—kidney cancer	0.000286	0.000439	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—kidney cancer	0.000286	0.00243	CbGpPWpGaD
Cyproterone acetate—Breast disorder—Doxorubicin—kidney cancer	0.000286	0.000438	CcSEcCtD
Cyproterone acetate—Skin disorder—Paclitaxel—kidney cancer	0.000285	0.000438	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	0.000285	0.00242	CbGpPWpGaD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000285	0.000437	CcSEcCtD
Cyproterone acetate—Headache—Sorafenib—kidney cancer	0.000285	0.000437	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000284	0.000436	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	0.000284	0.00241	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Dactinomycin—kidney cancer	0.000283	0.000434	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	0.000283	0.00241	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000281	0.00239	CbGpPWpGaD
Cyproterone acetate—Anorexia—Paclitaxel—kidney cancer	0.00028	0.000429	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—kidney cancer	0.000279	0.000428	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000279	0.000428	CcSEcCtD
Cyproterone acetate—Vomiting—Sunitinib—kidney cancer	0.000278	0.000426	CcSEcCtD
Cyproterone acetate—Body temperature increased—Gemcitabine—kidney cancer	0.000277	0.000425	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000277	0.00236	CbGpPWpGaD
Cyproterone acetate—Rash—Sunitinib—kidney cancer	0.000276	0.000423	CcSEcCtD
Cyproterone acetate—Dermatitis—Sunitinib—kidney cancer	0.000275	0.000422	CcSEcCtD
Cyproterone acetate—Hypotension—Paclitaxel—kidney cancer	0.000274	0.000421	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Capecitabine—kidney cancer	0.000274	0.00042	CcSEcCtD
Cyproterone acetate—Headache—Sunitinib—kidney cancer	0.000274	0.00042	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	0.000274	0.00233	CbGpPWpGaD
Cyproterone acetate—Asthma—Doxorubicin—kidney cancer	0.000273	0.000419	CcSEcCtD
Cyproterone acetate—Anaemia—Capecitabine—kidney cancer	0.000273	0.000419	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vincristine—kidney cancer	0.000272	0.000418	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000271	0.00231	CbGpPWpGaD
Cyproterone acetate—Nausea—Sorafenib—kidney cancer	0.00027	0.000414	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.00027	0.00229	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Doxorubicin—kidney cancer	0.000268	0.000411	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000267	0.00227	CbGpPWpGaD
Cyproterone acetate—Malaise—Capecitabine—kidney cancer	0.000266	0.000409	CcSEcCtD
Cyproterone acetate—Asthenia—Vincristine—kidney cancer	0.000265	0.000407	CcSEcCtD
Cyproterone acetate—Syncope—Capecitabine—kidney cancer	0.000265	0.000406	CcSEcCtD
Cyproterone acetate—Leukopenia—Capecitabine—kidney cancer	0.000264	0.000405	CcSEcCtD
Cyproterone acetate—Vomiting—Dactinomycin—kidney cancer	0.000263	0.000404	CcSEcCtD
Cyproterone acetate—Dyspnoea—Paclitaxel—kidney cancer	0.000262	0.000402	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—kidney cancer	0.000261	0.0004	CcSEcCtD
Cyproterone acetate—Nausea—Sunitinib—kidney cancer	0.00026	0.000398	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Capecitabine—kidney cancer	0.00026	0.000398	CcSEcCtD
Cyproterone acetate—Dyspepsia—Paclitaxel—kidney cancer	0.000259	0.000397	CcSEcCtD
Cyproterone acetate—Cough—Capecitabine—kidney cancer	0.000258	0.000395	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ACY1—kidney cancer	0.000257	0.00218	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	0.000256	0.00218	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Paclitaxel—kidney cancer	0.000255	0.000392	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000254	0.000389	CcSEcCtD
Cyproterone acetate—Fatigue—Paclitaxel—kidney cancer	0.000253	0.000388	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vincristine—kidney cancer	0.000253	0.000388	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—kidney cancer	0.000252	0.000387	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000252	0.00214	CbGpPWpGaD
Cyproterone acetate—Asthenia—Gemcitabine—kidney cancer	0.000252	0.000386	CcSEcCtD
Cyproterone acetate—Constipation—Paclitaxel—kidney cancer	0.000251	0.000385	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00025	0.000383	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	0.000249	0.00212	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000249	0.000383	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—kidney cancer	0.000249	0.000381	CcSEcCtD
Cyproterone acetate—Discomfort—Capecitabine—kidney cancer	0.000248	0.000381	CcSEcCtD
Cyproterone acetate—Pruritus—Gemcitabine—kidney cancer	0.000248	0.000381	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF5B—kidney cancer	0.000247	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000247	0.0021	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Doxorubicin—kidney cancer	0.000247	0.000379	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000246	0.000378	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—kidney cancer	0.000246	0.000377	CcSEcCtD
Cyproterone acetate—Dizziness—Vincristine—kidney cancer	0.000244	0.000375	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000244	0.00208	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Paclitaxel—kidney cancer	0.000242	0.000371	CcSEcCtD
Cyproterone acetate—Oedema—Capecitabine—kidney cancer	0.000241	0.00037	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00024	0.000368	CcSEcCtD
Cyproterone acetate—Diarrhoea—Gemcitabine—kidney cancer	0.00024	0.000368	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—kidney cancer	0.000239	0.000367	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000238	0.00203	CbGpPWpGaD
Cyproterone acetate—Jaundice—Doxorubicin—kidney cancer	0.000237	0.000364	CcSEcCtD
Cyproterone acetate—Shock—Capecitabine—kidney cancer	0.000237	0.000364	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Capecitabine—kidney cancer	0.000236	0.000363	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Capecitabine—kidney cancer	0.000236	0.000362	CcSEcCtD
Cyproterone acetate—Tachycardia—Capecitabine—kidney cancer	0.000235	0.000361	CcSEcCtD
Cyproterone acetate—Vomiting—Vincristine—kidney cancer	0.000235	0.000361	CcSEcCtD
Cyproterone acetate—Skin disorder—Capecitabine—kidney cancer	0.000234	0.000359	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—kidney cancer	0.000234	0.000358	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000233	0.00199	CbGpPWpGaD
Cyproterone acetate—Urticaria—Paclitaxel—kidney cancer	0.000233	0.000358	CcSEcCtD
Cyproterone acetate—Rash—Vincristine—kidney cancer	0.000233	0.000358	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Capecitabine—kidney cancer	0.000233	0.000357	CcSEcCtD
Cyproterone acetate—Dermatitis—Vincristine—kidney cancer	0.000233	0.000357	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—kidney cancer	0.000232	0.000356	CcSEcCtD
Cyproterone acetate—Body temperature increased—Paclitaxel—kidney cancer	0.000232	0.000356	CcSEcCtD
Cyproterone acetate—Abdominal pain—Paclitaxel—kidney cancer	0.000232	0.000356	CcSEcCtD
Cyproterone acetate—Headache—Vincristine—kidney cancer	0.000232	0.000355	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00023	0.000353	CcSEcCtD
Cyproterone acetate—Anorexia—Capecitabine—kidney cancer	0.00023	0.000352	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	0.000228	0.00194	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000226	0.00192	CbGpPWpGaD
Cyproterone acetate—Hypotension—Capecitabine—kidney cancer	0.000225	0.000345	CcSEcCtD
Cyproterone acetate—Vomiting—Gemcitabine—kidney cancer	0.000223	0.000342	CcSEcCtD
Cyproterone acetate—Rash—Gemcitabine—kidney cancer	0.000221	0.000339	CcSEcCtD
Cyproterone acetate—Dermatitis—Gemcitabine—kidney cancer	0.000221	0.000339	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—kidney cancer	0.00022	0.000337	CcSEcCtD
Cyproterone acetate—Headache—Gemcitabine—kidney cancer	0.00022	0.000337	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—kidney cancer	0.00022	0.000337	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000219	0.00186	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Doxorubicin—kidney cancer	0.000219	0.000335	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—kidney cancer	0.000219	0.000335	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PDHB—kidney cancer	0.000218	0.00186	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—kidney cancer	0.000217	0.00185	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Paclitaxel—kidney cancer	0.000216	0.000332	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000215	0.00033	CcSEcCtD
Cyproterone acetate—Dyspnoea—Capecitabine—kidney cancer	0.000215	0.00033	CcSEcCtD
Cyproterone acetate—Dyspepsia—Capecitabine—kidney cancer	0.000212	0.000325	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000212	0.0018	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Doxorubicin—kidney cancer	0.000211	0.000323	CcSEcCtD
Cyproterone acetate—Asthenia—Paclitaxel—kidney cancer	0.000211	0.000323	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EEF2—kidney cancer	0.00021	0.00179	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Capecitabine—kidney cancer	0.000209	0.000321	CcSEcCtD
Cyproterone acetate—Nausea—Gemcitabine—kidney cancer	0.000208	0.00032	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000208	0.000319	CcSEcCtD
Cyproterone acetate—Fatigue—Capecitabine—kidney cancer	0.000208	0.000319	CcSEcCtD
Cyproterone acetate—Pruritus—Paclitaxel—kidney cancer	0.000208	0.000319	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—kidney cancer	0.000207	0.000317	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	0.000206	0.00175	CbGpPWpGaD
Cyproterone acetate—Constipation—Capecitabine—kidney cancer	0.000206	0.000316	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CCBL1—kidney cancer	0.000205	0.00175	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Doxorubicin—kidney cancer	0.000204	0.000313	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000202	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000202	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000202	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TET2—kidney cancer	0.000201	0.00171	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Paclitaxel—kidney cancer	0.000201	0.000308	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.0002	0.0017	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Capecitabine—kidney cancer	0.000199	0.000305	CcSEcCtD
Cyproterone acetate—Angiopathy—Doxorubicin—kidney cancer	0.000198	0.000304	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—kidney cancer	0.000197	0.000303	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000197	0.000302	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000197	0.000302	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000197	0.00167	CbGpPWpGaD
Cyproterone acetate—Chills—Doxorubicin—kidney cancer	0.000196	0.000301	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	0.000196	0.00167	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000195	0.00166	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000195	0.00166	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000194	0.00165	CbGpPWpGaD
Cyproterone acetate—Dizziness—Paclitaxel—kidney cancer	0.000194	0.000298	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—kidney cancer	0.000193	0.000296	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000192	0.00163	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Doxorubicin—kidney cancer	0.000192	0.000294	CcSEcCtD
Cyproterone acetate—Urticaria—Capecitabine—kidney cancer	0.000191	0.000294	CcSEcCtD
Cyproterone acetate—Abdominal pain—Capecitabine—kidney cancer	0.000191	0.000292	CcSEcCtD
Cyproterone acetate—Body temperature increased—Capecitabine—kidney cancer	0.000191	0.000292	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—kidney cancer	0.00019	0.000292	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.00019	0.00161	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	0.000187	0.00159	CbGpPWpGaD
Cyproterone acetate—Tension—Doxorubicin—kidney cancer	0.000187	0.000287	CcSEcCtD
Cyproterone acetate—Vomiting—Paclitaxel—kidney cancer	0.000187	0.000286	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000186	0.00158	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000185	0.00158	CbGpPWpGaD
Cyproterone acetate—Rash—Paclitaxel—kidney cancer	0.000185	0.000284	CcSEcCtD
Cyproterone acetate—Dermatitis—Paclitaxel—kidney cancer	0.000185	0.000284	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—TCEB1—kidney cancer	0.000184	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TCEB2—kidney cancer	0.000184	0.00157	CbGpPWpGaD
Cyproterone acetate—Headache—Paclitaxel—kidney cancer	0.000184	0.000282	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GLIPR1—kidney cancer	0.000178	0.00151	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPAT—kidney cancer	0.000178	0.00151	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Capecitabine—kidney cancer	0.000178	0.000272	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—kidney cancer	0.000177	0.000271	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000176	0.0015	CbGpPWpGaD
Cyproterone acetate—Anaemia—Doxorubicin—kidney cancer	0.000176	0.00027	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000176	0.00149	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000176	0.00149	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—kidney cancer	0.000175	0.000268	CcSEcCtD
Cyproterone acetate—Nausea—Paclitaxel—kidney cancer	0.000174	0.000268	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000174	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000174	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000174	0.00148	CbGpPWpGaD
Cyproterone acetate—Asthenia—Capecitabine—kidney cancer	0.000173	0.000265	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000172	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000172	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000172	0.00146	CbGpPWpGaD
Cyproterone acetate—Malaise—Doxorubicin—kidney cancer	0.000172	0.000263	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—kidney cancer	0.000171	0.00146	CbGpPWpGaD
Cyproterone acetate—Syncope—Doxorubicin—kidney cancer	0.000171	0.000262	CcSEcCtD
Cyproterone acetate—Pruritus—Capecitabine—kidney cancer	0.000171	0.000262	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—kidney cancer	0.00017	0.000261	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000168	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000168	0.00143	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Doxorubicin—kidney cancer	0.000167	0.000257	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000167	0.00142	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—kidney cancer	0.000166	0.000255	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000166	0.00141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APRT—kidney cancer	0.000165	0.00141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FH—kidney cancer	0.000165	0.00141	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Capecitabine—kidney cancer	0.000165	0.000253	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	0.000165	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000162	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000162	0.00138	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000162	0.00138	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000161	0.000247	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	0.000161	0.00137	CbGpPWpGaD
Cyproterone acetate—Discomfort—Doxorubicin—kidney cancer	0.00016	0.000246	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EEF2—kidney cancer	0.000159	0.00136	CbGpPWpGaD
Cyproterone acetate—Dizziness—Capecitabine—kidney cancer	0.000159	0.000244	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000159	0.00135	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPC3—kidney cancer	0.000155	0.00132	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—kidney cancer	0.000155	0.000238	CcSEcCtD
Cyproterone acetate—Vomiting—Capecitabine—kidney cancer	0.000153	0.000235	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—kidney cancer	0.000153	0.000234	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—TET2—kidney cancer	0.000153	0.0013	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—kidney cancer	0.000152	0.000234	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—kidney cancer	0.000152	0.000233	CcSEcCtD
Cyproterone acetate—Rash—Capecitabine—kidney cancer	0.000152	0.000233	CcSEcCtD
Cyproterone acetate—Dermatitis—Capecitabine—kidney cancer	0.000152	0.000233	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000152	0.00129	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Doxorubicin—kidney cancer	0.000152	0.000233	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CA2—kidney cancer	0.000151	0.00129	CbGpPWpGaD
Cyproterone acetate—Headache—Capecitabine—kidney cancer	0.000151	0.000232	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—kidney cancer	0.000151	0.000231	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—kidney cancer	0.00015	0.00023	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.00015	0.00127	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL14—kidney cancer	0.00015	0.00127	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000149	0.00127	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—kidney cancer	0.000148	0.000227	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000148	0.00126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALAD—kidney cancer	0.000147	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000146	0.00124	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—kidney cancer	0.000145	0.000223	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ST3GAL2—kidney cancer	0.000144	0.00122	CbGpPWpGaD
Cyproterone acetate—Nausea—Capecitabine—kidney cancer	0.000143	0.00022	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ALDH1A1—kidney cancer	0.000141	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TCEB2—kidney cancer	0.00014	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TCEB1—kidney cancer	0.00014	0.00119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.00014	0.00119	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—kidney cancer	0.000138	0.000212	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000138	0.00118	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Doxorubicin—kidney cancer	0.000137	0.00021	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000136	0.00116	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—kidney cancer	0.000135	0.000207	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PGK1—kidney cancer	0.000135	0.00115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A3—kidney cancer	0.000135	0.00115	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000134	0.00114	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000134	0.000206	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—kidney cancer	0.000134	0.000205	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000133	0.00113	CbGpPWpGaD
Cyproterone acetate—Constipation—Doxorubicin—kidney cancer	0.000133	0.000204	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—LDHB—kidney cancer	0.000132	0.00112	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000131	0.00112	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000131	0.00111	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.00013	0.00111	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000129	0.0011	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—kidney cancer	0.000128	0.000196	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000127	0.000195	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000124	0.00106	CbGpPWpGaD
Cyproterone acetate—Urticaria—Doxorubicin—kidney cancer	0.000123	0.000189	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—kidney cancer	0.000123	0.000188	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—kidney cancer	0.000123	0.000188	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EIF4EBP1—kidney cancer	0.000122	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPB1—kidney cancer	0.000122	0.00104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA9—kidney cancer	0.000115	0.000975	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000115	0.000975	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—kidney cancer	0.000114	0.000176	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000114	0.000971	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL14—kidney cancer	0.000114	0.000967	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PSMD7—kidney cancer	0.000113	0.000966	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000112	0.000953	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—kidney cancer	0.000111	0.000171	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.00011	0.000939	CbGpPWpGaD
Cyproterone acetate—Pruritus—Doxorubicin—kidney cancer	0.00011	0.000169	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—kidney cancer	0.000106	0.000163	CcSEcCtD
Cyproterone acetate—Dizziness—Doxorubicin—kidney cancer	0.000103	0.000158	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—JUNB—kidney cancer	0.000102	0.000867	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—kidney cancer	9.88e-05	0.000152	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—kidney cancer	9.79e-05	0.00015	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—kidney cancer	9.79e-05	0.00015	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CRABP1—kidney cancer	9.74e-05	0.000829	CbGpPWpGaD
Cyproterone acetate—Headache—Doxorubicin—kidney cancer	9.73e-05	0.000149	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	9.26e-05	0.000788	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPB1—kidney cancer	9.26e-05	0.000788	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—kidney cancer	9.23e-05	0.000142	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ITPR2—kidney cancer	9.06e-05	0.000771	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PSMD7—kidney cancer	8.61e-05	0.000733	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.35e-05	0.000711	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CDKN2B—kidney cancer	8.29e-05	0.000706	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—kidney cancer	8.26e-05	0.000703	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACHE—kidney cancer	8.26e-05	0.000703	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SCARB1—kidney cancer	7.82e-05	0.000665	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS1—kidney cancer	7.74e-05	0.000659	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—JUNB—kidney cancer	7.73e-05	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PSMD7—kidney cancer	7.59e-05	0.000646	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—kidney cancer	7.2e-05	0.000612	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—kidney cancer	7.11e-05	0.000605	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A1—kidney cancer	6.87e-05	0.000584	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—kidney cancer	6.67e-05	0.000568	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.66e-05	0.000567	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—kidney cancer	6.29e-05	0.000535	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.81e-05	0.000494	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—kidney cancer	5.73e-05	0.000487	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—kidney cancer	5.42e-05	0.000461	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—kidney cancer	5.26e-05	0.000448	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	5.06e-05	0.000431	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—kidney cancer	4.99e-05	0.000424	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.1e-05	0.000349	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—kidney cancer	3.72e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—kidney cancer	3.3e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—kidney cancer	3.21e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—kidney cancer	2.97e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—kidney cancer	2.59e-05	0.00022	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—kidney cancer	2.51e-05	0.000213	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—kidney cancer	2.44e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—kidney cancer	1.83e-05	0.000155	CbGpPWpGaD
